Steven George Hughes insider trades

Open-market stock purchases and sales by Steven George Hughes, Chief Medical Officer at Atrium Therapeutics, Inc, from SEC Form 4 filings since Aug 14, 2018.

Recent trades

DateStockTradeValue
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.2M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.7M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$324K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$696K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Jan 21, 2026RNA Avidity Biosciences, IncSold$146K
Jan 21, 2026RNA Avidity Biosciences, IncSold$209K
Jan 7, 2026RNA Avidity Biosciences, IncSold$171K
Oct 22, 2025RNA Avidity Biosciences, IncSold$105K
Oct 22, 2025RNA Avidity Biosciences, IncBought (not open market)—

Companies traded

  • RNA Atrium Therapeutics, Inc: 16 sales, last Apr 20, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026
  • ARCT Arcturus Therapeutics Holdings Inc: other filings, last Dec 18, 2020
  • ONVO Organovo Holdings, Inc: 1 sale, last Aug 16, 2019

Get free alerts when Steven George Hughes files a new trade →